Intranasal oxytocin does not modulate jumping to conclusions in schizophrenia: Potential interactions with caudate volume and baseline social functioning

Fernando Caravaggio, Philip Gerretsen, Wanna Mar, Jun Ku Chung, Eric Plitman, Shinichiro Nakajima, Julia Kim, Yusuke Iwata, Raihaan Patel, M. Mallar Chakravarty, Gary Remington, Ariel Graff-Guerrero, Mahesh Menon

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background Patients with schizophrenia (SCZ) tend to sample less information when making a decision, jumping to conclusions (JTC) without sufficient evidence. This “JTC bias” may be a trait marker of the disease and may not improve with antipsychotic treatment. We conducted a double-blind, placebo-controlled trial to test whether intranasal oxytocin could reduce JTC in stable, medicated patients with SCZ and healthy controls (HCs). We also explored whether striatal volume, clinical symptoms, and baseline social functioning (SF) was related to JTC performance. Methods Forty-three male, medicated SCZ patients (Mean Age: 40.81 ± 11.44) and sixteen HCs (Mean Age: 30.38 ± 9.85) participated in a double-blind, placebo-controlled, cross-over study. Participants completed the Beads Task on two separate visits (minimum 20 days apart). Participants were randomized to receive either intranasal oxytocin (50IU in solution) or intranasal placebo (saline). Twenty of the SCZ patients and all sixteen HCs also provided T1 MRIs (3-T). Results Patients with SCZ took fewer draws to decision (DTD) than HCs (t(57) = 2.78, p = 0.007). Oxytocin did not significantly change DTD in patients (t(42) = −1.11, p = 0.27), nor in HCs (t(15) = −0.62, p = 0.55). Exploratory analyses found ventral caudate volumes were negatively correlated with DTD (r(18) = −0.50, p = 0.03) in patients. Moreover, oxytocin was more likely to improve JTC in patients with lower baseline SF. However, these exploratory findings did not survive correction for multiple comparisons. Conclusions We replicate increased JTC in SCZ. However, acute intranasal oxytocin did not modify JTC. Future studies with larger samples should explore how brain morphology and SF are related to JTC performance in patients with SCZ.

Original languageEnglish
Pages (from-to)80-87
Number of pages8
JournalPsychoneuroendocrinology
Volume81
DOIs
Publication statusPublished - 2017 Jul 1

Fingerprint

Oxytocin
Schizophrenia
Placebos
Corpus Striatum
Cross-Over Studies
Antipsychotic Agents
Decision Making
Brain

Keywords

  • Beads task
  • Caudate
  • Jumping to conclusions
  • Morphometry
  • Oxytocin
  • Schizophrenia
  • Social cognition
  • Volume

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Endocrine and Autonomic Systems
  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Intranasal oxytocin does not modulate jumping to conclusions in schizophrenia : Potential interactions with caudate volume and baseline social functioning. / Caravaggio, Fernando; Gerretsen, Philip; Mar, Wanna; Chung, Jun Ku; Plitman, Eric; Nakajima, Shinichiro; Kim, Julia; Iwata, Yusuke; Patel, Raihaan; Chakravarty, M. Mallar; Remington, Gary; Graff-Guerrero, Ariel; Menon, Mahesh.

In: Psychoneuroendocrinology, Vol. 81, 01.07.2017, p. 80-87.

Research output: Contribution to journalArticle

Caravaggio, F, Gerretsen, P, Mar, W, Chung, JK, Plitman, E, Nakajima, S, Kim, J, Iwata, Y, Patel, R, Chakravarty, MM, Remington, G, Graff-Guerrero, A & Menon, M 2017, 'Intranasal oxytocin does not modulate jumping to conclusions in schizophrenia: Potential interactions with caudate volume and baseline social functioning', Psychoneuroendocrinology, vol. 81, pp. 80-87. https://doi.org/10.1016/j.psyneuen.2017.03.020
Caravaggio, Fernando ; Gerretsen, Philip ; Mar, Wanna ; Chung, Jun Ku ; Plitman, Eric ; Nakajima, Shinichiro ; Kim, Julia ; Iwata, Yusuke ; Patel, Raihaan ; Chakravarty, M. Mallar ; Remington, Gary ; Graff-Guerrero, Ariel ; Menon, Mahesh. / Intranasal oxytocin does not modulate jumping to conclusions in schizophrenia : Potential interactions with caudate volume and baseline social functioning. In: Psychoneuroendocrinology. 2017 ; Vol. 81. pp. 80-87.
@article{12f747fa482c418aac5273a2bdfea228,
title = "Intranasal oxytocin does not modulate jumping to conclusions in schizophrenia: Potential interactions with caudate volume and baseline social functioning",
abstract = "Background Patients with schizophrenia (SCZ) tend to sample less information when making a decision, jumping to conclusions (JTC) without sufficient evidence. This “JTC bias” may be a trait marker of the disease and may not improve with antipsychotic treatment. We conducted a double-blind, placebo-controlled trial to test whether intranasal oxytocin could reduce JTC in stable, medicated patients with SCZ and healthy controls (HCs). We also explored whether striatal volume, clinical symptoms, and baseline social functioning (SF) was related to JTC performance. Methods Forty-three male, medicated SCZ patients (Mean Age: 40.81 ± 11.44) and sixteen HCs (Mean Age: 30.38 ± 9.85) participated in a double-blind, placebo-controlled, cross-over study. Participants completed the Beads Task on two separate visits (minimum 20 days apart). Participants were randomized to receive either intranasal oxytocin (50IU in solution) or intranasal placebo (saline). Twenty of the SCZ patients and all sixteen HCs also provided T1 MRIs (3-T). Results Patients with SCZ took fewer draws to decision (DTD) than HCs (t(57) = 2.78, p = 0.007). Oxytocin did not significantly change DTD in patients (t(42) = −1.11, p = 0.27), nor in HCs (t(15) = −0.62, p = 0.55). Exploratory analyses found ventral caudate volumes were negatively correlated with DTD (r(18) = −0.50, p = 0.03) in patients. Moreover, oxytocin was more likely to improve JTC in patients with lower baseline SF. However, these exploratory findings did not survive correction for multiple comparisons. Conclusions We replicate increased JTC in SCZ. However, acute intranasal oxytocin did not modify JTC. Future studies with larger samples should explore how brain morphology and SF are related to JTC performance in patients with SCZ.",
keywords = "Beads task, Caudate, Jumping to conclusions, Morphometry, Oxytocin, Schizophrenia, Social cognition, Volume",
author = "Fernando Caravaggio and Philip Gerretsen and Wanna Mar and Chung, {Jun Ku} and Eric Plitman and Shinichiro Nakajima and Julia Kim and Yusuke Iwata and Raihaan Patel and Chakravarty, {M. Mallar} and Gary Remington and Ariel Graff-Guerrero and Mahesh Menon",
year = "2017",
month = "7",
day = "1",
doi = "10.1016/j.psyneuen.2017.03.020",
language = "English",
volume = "81",
pages = "80--87",
journal = "Psychoneuroendocrinology",
issn = "0306-4530",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Intranasal oxytocin does not modulate jumping to conclusions in schizophrenia

T2 - Potential interactions with caudate volume and baseline social functioning

AU - Caravaggio, Fernando

AU - Gerretsen, Philip

AU - Mar, Wanna

AU - Chung, Jun Ku

AU - Plitman, Eric

AU - Nakajima, Shinichiro

AU - Kim, Julia

AU - Iwata, Yusuke

AU - Patel, Raihaan

AU - Chakravarty, M. Mallar

AU - Remington, Gary

AU - Graff-Guerrero, Ariel

AU - Menon, Mahesh

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Background Patients with schizophrenia (SCZ) tend to sample less information when making a decision, jumping to conclusions (JTC) without sufficient evidence. This “JTC bias” may be a trait marker of the disease and may not improve with antipsychotic treatment. We conducted a double-blind, placebo-controlled trial to test whether intranasal oxytocin could reduce JTC in stable, medicated patients with SCZ and healthy controls (HCs). We also explored whether striatal volume, clinical symptoms, and baseline social functioning (SF) was related to JTC performance. Methods Forty-three male, medicated SCZ patients (Mean Age: 40.81 ± 11.44) and sixteen HCs (Mean Age: 30.38 ± 9.85) participated in a double-blind, placebo-controlled, cross-over study. Participants completed the Beads Task on two separate visits (minimum 20 days apart). Participants were randomized to receive either intranasal oxytocin (50IU in solution) or intranasal placebo (saline). Twenty of the SCZ patients and all sixteen HCs also provided T1 MRIs (3-T). Results Patients with SCZ took fewer draws to decision (DTD) than HCs (t(57) = 2.78, p = 0.007). Oxytocin did not significantly change DTD in patients (t(42) = −1.11, p = 0.27), nor in HCs (t(15) = −0.62, p = 0.55). Exploratory analyses found ventral caudate volumes were negatively correlated with DTD (r(18) = −0.50, p = 0.03) in patients. Moreover, oxytocin was more likely to improve JTC in patients with lower baseline SF. However, these exploratory findings did not survive correction for multiple comparisons. Conclusions We replicate increased JTC in SCZ. However, acute intranasal oxytocin did not modify JTC. Future studies with larger samples should explore how brain morphology and SF are related to JTC performance in patients with SCZ.

AB - Background Patients with schizophrenia (SCZ) tend to sample less information when making a decision, jumping to conclusions (JTC) without sufficient evidence. This “JTC bias” may be a trait marker of the disease and may not improve with antipsychotic treatment. We conducted a double-blind, placebo-controlled trial to test whether intranasal oxytocin could reduce JTC in stable, medicated patients with SCZ and healthy controls (HCs). We also explored whether striatal volume, clinical symptoms, and baseline social functioning (SF) was related to JTC performance. Methods Forty-three male, medicated SCZ patients (Mean Age: 40.81 ± 11.44) and sixteen HCs (Mean Age: 30.38 ± 9.85) participated in a double-blind, placebo-controlled, cross-over study. Participants completed the Beads Task on two separate visits (minimum 20 days apart). Participants were randomized to receive either intranasal oxytocin (50IU in solution) or intranasal placebo (saline). Twenty of the SCZ patients and all sixteen HCs also provided T1 MRIs (3-T). Results Patients with SCZ took fewer draws to decision (DTD) than HCs (t(57) = 2.78, p = 0.007). Oxytocin did not significantly change DTD in patients (t(42) = −1.11, p = 0.27), nor in HCs (t(15) = −0.62, p = 0.55). Exploratory analyses found ventral caudate volumes were negatively correlated with DTD (r(18) = −0.50, p = 0.03) in patients. Moreover, oxytocin was more likely to improve JTC in patients with lower baseline SF. However, these exploratory findings did not survive correction for multiple comparisons. Conclusions We replicate increased JTC in SCZ. However, acute intranasal oxytocin did not modify JTC. Future studies with larger samples should explore how brain morphology and SF are related to JTC performance in patients with SCZ.

KW - Beads task

KW - Caudate

KW - Jumping to conclusions

KW - Morphometry

KW - Oxytocin

KW - Schizophrenia

KW - Social cognition

KW - Volume

UR - http://www.scopus.com/inward/record.url?scp=85017634882&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017634882&partnerID=8YFLogxK

U2 - 10.1016/j.psyneuen.2017.03.020

DO - 10.1016/j.psyneuen.2017.03.020

M3 - Article

C2 - 28431278

AN - SCOPUS:85017634882

VL - 81

SP - 80

EP - 87

JO - Psychoneuroendocrinology

JF - Psychoneuroendocrinology

SN - 0306-4530

ER -